13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
|
Name |
WKN |
Börse |
Kurs |
Datum/Zeit |
Diff. |
Diff. % |
Geld |
Brief |
Erster |
Schluss |
![](/mel/img/quote_button.gif) |
SANOFI SA INHABER EO 2 |
920657 |
Xetra |
86,410 |
17.06.24 09:39:37 |
-0,330 |
-0,38% |
86,170 |
86,230 |
86,620 |
86,740 |
![](/mel/img/quote_button.gif) |
REGENERON PHARMAC.DL-,001 |
881535 |
Frankfurt |
967,800 |
17.06.24 08:10:52 |
+15,000 |
+1,57% |
967,800 |
976,000 |
967,800 |
952,800 |